SYRE
Spyre Therapeutics Inc.
$15.29
+$0.41(+2.76%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$898.77M
Volume
608.14K
52W Range
$10.91 - $40.26
Target Price
$53.90
EPS Estimates Overview
| Current Quarter | $-0.75 | Next Quarter | $-0.77 |
| Current Year | $-2.87 | Next Year | $-3.14 |
| QoQ Growth | -2.7% | YoY Growth | -9.4% |
| 3Y EPS CAGR | +0.0% | Target Price | $53.90 |
| Consensus | Buy | Upside | +252.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $15.29 | +2.8% | 608.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |